Novel materials which possess the ability to target liver cells

Bibliography

• Wu J, Zern MA. Hepatic stellate cells, a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665-7
   PubMed Web of Science ®Google Scholar
• Orfila C, Lepert JC, Alric L, Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem J 1999;31:677-85
   PubMedGoogle Scholar
• Mavier P, Mallat A. Perspectives in the treatment of liver fibrosis. J Hepatol 1995;111(22):5
   Google Scholar
• Meijer DKF, Molema G. Targeting of drugs to the liver. Semin Liver Dis 1995;202(15):56
   Google Scholar
• Kawakami S, Sato A, Nishikawa M, Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000;7:292
   PubMed Web of Science ®Google Scholar
• Sato A, Kawakami S, Yamada M, Enhanced gene Transfection in macrophages using mannosylated cationic liposomes-polyethyleneimine-plasmid. DNA complexes. J Drug Target 2001;9:201
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Takemura S, Yamashita F, Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice. J Drug Target 2000;8:29
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Nishikawa M, Kawakami S, Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Int J Pharm 2004;287:147-54
   PubMed Web of Science ®Google Scholar
• Bianucci AM, Shiellini F. A 3d model for the human hepatic asialoglycoprotein receptor (ASGP-R). J Biomol Struct Dyn 2000;18:435-51
   PubMed Web of Science ®Google Scholar
• Wu DQ, Lu B, Chang C, Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterials 2009;30:1363-71
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhang XQ, Xiong FL, Preparation, characterization, and tissue distribution in mice of lactosaminated carboxymethyl chitosan nanoparticles. Carbohydr Polymers 2011;83:1139-45
   Web of Science ®Google Scholar
• Zhang C, Ping Q, Ding Y. Synthesis and characterization of chitosan derivatives carrying galactose residues. Journal of Applied Polymer Science 2005;97:2161-7
   Web of Science ®Google Scholar
• Wang SN, Deng YH, Xu Hui, Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm 2006;62:32-8
   PubMed Web of Science ®Google Scholar
• Kamruzzaman Selim KM, Ha YS, Kim SJ, Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 2007;28:710-16
   PubMed Web of Science ®Google Scholar
• Keiichi M, Yoshihiro N, Yukihiko A, In vitro gene delivery mediated by asialofetuin-appended cationic liposomes associated with gamma-cyclodextrin into hepatocytes. J Drug Deliv 2011, Article ID 476137, 1.
   Google Scholar
• Gagandeep K. Asialofetuin-coated PLGA Nanoparticles for Targeting Hepatocytes. DSpace Software 2010;8:31
   Google Scholar
• Qi XR, Yan WW, Shi J. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol. World J Gastroenterol 2005;11:4947-52
   PubMed Web of Science ®Google Scholar
• Maitani Y, Kawano K, Yamado K, Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in Hep G2 cells. J Control Release 2001;75:381-9
   PubMed Web of Science ®Google Scholar
• Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008;22:709-24
   PubMed Web of Science ®Google Scholar
• Fiore C, Eisenhut M, Krausse R, Antiviral effects of Glycyrrhiza species. Phytother Res 2008;22:141-8
   PubMed Web of Science ®Google Scholar
• Mao SJ, Bi YQ, Jin H, Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazie 2007;62:614-19
   PubMed Web of Science ®Google Scholar
• Satomi Y, Nishino H, Shibata S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anti Cancer Res 2005;25:4043-7
   PubMed Web of Science ®Google Scholar
• He ZY, Zheng Xi, Wu XH, Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. International Journal of Pharmaceutics 2010;397:147-54
   PubMed Web of Science ®Google Scholar
• Tian Q, Zhang CN, Wang XH, Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 2010;31:4748-56
   PubMed Web of Science ®Google Scholar
• Popielarski SR, Pun SH, Davis ME. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization. Bioconjug Chem 2005;16:1063-70
   PubMed Web of Science ®Google Scholar
• Chen ZP, Zhu JB, Chen HX, Synthesis of a novel polymer bile salts-(poly ethylene glycol) 2000-bile salts and its application to the liver-selective targeting of liposomal DDB. Drug Dev Ind Pharm 2010;36:657-65
   PubMed Web of Science ®Google Scholar
• East L, Isacke CM. The mannose receptor family. Biochim Biophys Acta 2002;1572:364-86
   Google Scholar
• Aswathy J, Sajith S, Manzoor K, Mannosylated chitosan-zinc sulphide nanocrystals as fluorescent bioprobes for targeted cancer imaging. Carbohydr Polymers 2011;85:37-43
   Web of Science ®Google Scholar
• Rieger J, Freichels H, Imberty A, Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 2009;10:651-7
   PubMed Web of Science ®Google Scholar
• Chuang VT, Hansen KU, Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 2002;19:569-77
   PubMed Web of Science ®Google Scholar
• Sungeun K, Jae MJ, Mee KH, Differential receptor targeting of liver cells using 99mTc-neoglycosylated human serum albumins. Arch Pharm Res 2008;31:60-6
   PubMed Web of Science ®Google Scholar
• Kawakami S, Sato A, Nishikawa M, Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000;7:292
   PubMed Web of Science ®Google Scholar
• Beljaars L, Olinga P, Molema G, Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Liver 2001;21:320-8
   PubMedGoogle Scholar
• Sato A, Kawakami S, Yamada M, Enhanced gene Transfection in macrophages using mannosylated cationic liposomes-polyethyleneimine-plasmid DNA complexes. J. Drug Target 2001;9:201
   PubMed Web of Science ®Google Scholar
• Ankita V, Pariyankar S, Ejaz A, Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 2010;22:77-87
   PubMed Web of Science ®Google Scholar
• Kenshiro H, Toru M, Hiroshi W, Genetically engineered mannosylated-human serum albumin as a versatile carrier. Journal of Controlled Release 2010;145:9-16
   PubMed Web of Science ®Google Scholar
• Simard JR, Zunszain PA, Ha CE, Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. Proc Natl Acad Sci USA 2005;102:17958-63
   PubMed Web of Science ®Google Scholar
• Yabe Y, Kobayashi N, Nishikawa M, Pharmacokinetics and preventive effects of targeted catalase derivatives on hydrogen peroxide-induced injury in perfused rat liver. Pharm Res 2002;19:1815-21
   PubMed Web of Science ®Google Scholar
• Jeong JM, Hong MK, Lee J, 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor. Bioconjug Chem 2004a;15:850-5
   PubMed Web of Science ®Google Scholar
• Jeong JM, Hong MK, Kim YJ, Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging. Nucl Med Commun 2004b;25:1211-17
   PubMed Web of Science ®Google Scholar
• Guo J, Friedman SL. Hepatic fibrogenesis. Semin Liver Dis 2007;27:413-26
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18
   PubMed Web of Science ®Google Scholar
• Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002;122:1525-8
   PubMed Web of Science ®Google Scholar
• Issa R, Zhou X, Constandinou CM, Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004;126:1795-808
   PubMed Web of Science ®Google Scholar
• Muriel P, Moreno MG, Hernandez MC, Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Basic Clin Pharmacol Toxicol 2005;96:375-80
   PubMed Web of Science ®Google Scholar
• Breitkopf K, Roeyen C, Sawitza I, Expression patterns of PDGF-A -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC). Cytokine 2005;31:349-57
   PubMed Web of Science ®Google Scholar
• Novosyadlyy R, Tron K, Dudas J, Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts. J Cell Physiol 2004;199:388-98
   PubMed Web of Science ®Google Scholar
• Greupink R, Bakker HI, Reker-Smit C, Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J Hepatol 2005;43:884-92
   PubMed Web of Science ®Google Scholar
• Greupink R, Bakker HI, Van GH, Mannose-6-phosphate/insulin-like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells. Pharm Res 2006;23:1827-34
   PubMed Web of Science ®Google Scholar
• Greupink R, Bakker HI, Bouma W, The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. J Pharmacol Exp Ther 2006;317:514-21
   PubMed Web of Science ®Google Scholar
• Greupink R, Reker-Smit C, Proost JH, Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats. Biochem Pharmacol 2007;73:1455-62
   PubMed Web of Science ®Google Scholar
• Hagens WI, Mattos A, Greupink R, Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. Pharm Res 2007;24:566-74
   PubMed Web of Science ®Google Scholar
• Hagens WI, Beljaars L, Mann DA, Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther 2008;324:902-10
   PubMed Web of Science ®Google Scholar
• Adrian JE, Kamps JA, Poelstra K, Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes. J Drug Target 2007;15:75-82
   PubMed Web of Science ®Google Scholar
• Gonzalo T, Talman EG, Van DV, Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. J Control Release 2006;111:193-203
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Reker-Smit C, Lub-de Hooge MN, Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine. Drug Metab Dispos 2007;35:814-21
   PubMed Web of Science ®Google Scholar
• Moreno M, Gonzalo T, Kok RJ, Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology 2010;51:942-52
   PubMed Web of Science ®Google Scholar